Skip to content

Low-Carbohydrate and Plant-Based Dietary Effects on Vascular Health

Short-term Effects of a Low-carbohydrate Diet and a Whole-food, Plant-based Diet on Newer Markers of Vascular Health

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05414851
Enrollment
45
Registered
2022-06-10
Start date
2022-12-20
Completion date
2024-04-23
Last updated
2024-07-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Disease, Ischemic, Hyperlipidemias, Hypertension

Brief summary

This is a randomized trial with a crossover design to investigate the short-term effects of two different dietary patterns on markers of vascular health. A low-carbohydrate diet and a whole-food, plant-based diet will be used. In addition to more traditional markers (cholesterol, blood pressure, inflammation), endothelial progenitor cells and trimethylamine N-oxide will be assessed.

Detailed description

This study is an investigation of the short-term effects of two different diets on both conventional as well as newer markers of vascular health among subjects over the age of 50 who have a cardiovascular risk factor. The low-carbohydrate diet will be consistent with low-carbohydrate diet maintenance plans, with net carbs kept under 50g per day. The whole-food, plant-based diet will exclude animal foods, oils, and solid fats. Meals will be provided, and subjects will consume each diet for 2 weeks, with a 4-6 week washout period between dietary phases. Subjects will be randomized 1:1 to start with either the plant-based diet or the low-carbohydrate diet. Its primary aim is to assess the short-term effect of a whole-food, plant-based diet and a low-carbohydrate diet on levels of endothelial progenitor cells and trimethylamine N-oxide among this population. Secondarily, we will assess more conventional measures of vascular risk, including cholesterol, weight, blood pressure, insulin resistance, and inflammatory marker, as well as fullness and changes in nutritional intake.

Interventions

OTHERWhole-Food, Plant-Based Diet and Low-Carbohydrate Diet

Participants will consume two weeks of each diet, with a 4-6 week washout period in between. Meals and snacks are provided for convenience to enhance adherence to each dietary pattern, but subjects can add or include their own home-prepared foods as long as they meet dietary guidelines. Each dietary intervention will include an education session via Zoom teleconference, and at least 2 individual contacts by phone to address questions and assess for adverse events.

Sponsors

University of Rochester
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Masking description

Laboratory personnel will not know which dietary phase each subject has completed, but otherwise blinding is not possible.

Intervention model description

All subjects will consume two separate diets, with a 4-6 washout in between. They will be randomized 1:1 to determine which diet they start with.

Eligibility

Sex/Gender
ALL
Age
50 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age \>50 * Diagnosis of any of the following cardiovascular risk factors: hypertension (Diagnosis present in chart or use of antihypertensive medications); hyperlipidemia/dyslipidemia (non-HDL cholesterol ≥ 130 within the past year or current use of antihyperlipidemic medication); prediabetes (HbA1c ≥ 5.7% and \< 6.5% in the past year); diabetes (HbA1c ≥ 6.5% in the past year); obesity (body mass index ≥ 30). * Willing and able to comply with the protocol for the duration of the study, including food provision, scheduled meetings and testing visits. * Able to speak and read English fluently because counseling and education is only available in English.

Exclusion criteria

* Active malabsorption syndrome (celiac disease, history of gastric bypass within the past year, uncontrolled Crohn's disease, protein-losing enteropathy, etc…) * Use of any of the following medications that require close monitoring and adjustment during major dietary change: insulin, sulfonylureas, or warfarin * Chronic or acute kidney disease, with eGFR \< 50 on two or more lab tests in the past 6 months * Diagnosis of cirrhosis or liver failure * Hyperkalemia (defined as potassium \>5.4 on two or more lab tests in the past 6 months) * Major surgery in the past 3 months * Myocardial infarction in the past 6 months * Current, active eating disorder as determined by chart review, investigator assessment, or subject history * Food allergies or intolerances that would interfere with eating study food or require special accommodation as determined by subject history, investigator assessment, or chart review * Consuming a current diet described by the subject as vegetarian, vegan, very low-carbohydrate, or ketogenic * Illicit drug use (not including marijuana) * High risk alcohol use, based on subject history (defined as greater than 7 drinks/week for women and greater than 14 drinks/week for men)

Design outcomes

Primary

MeasureTime frame
Endothelial Progenitor Cells2 weeks
trimethylamine N-oxide2 weeks
HDL function2 weeks

Secondary

MeasureTime frameDescription
Weight2 weeks
Insulin resistance2 weeksHOMA-IR
Insulin2 weeks
Blood Glucose2 weeks
Cholesterol Panel2 weeksTotal, LDL, HDL, non-HDL cholesterol, and triglycerides
Satiety Assessment2 weeksAdapted SLIM (satiety labeled intensity magnitude)
Food liking2 weeks5 food liking factor scales adapted from 5-Factor Satiety Questionnaires
Change in nutritional intake2 weeksassessed by 3 day food records at baseline and in second week of dietary phase
Inflammatory Markers2 weekshsCRP, TNF-a, IL-6
Blood Pressure2 Weeks
Resting Heart Rate2 weeks

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026